Trump's biosecurity rollback is why AI CEOs are begging Congress now
08 June 2026

Trump's biosecurity rollback is why AI CEOs are begging Congress now

BotCity

About
Sam Altman, Dario Amodei, Demis Hassabis, and Mustafa Suleyman co-signed a letter to Congress this week asking for mandatory screening on synthetic DNA orders — citing evidence that AI systems now outperform PhD-level virologists on lab procedure questions. What the letter frames as a fresh bipartisan opportunity has a quieter backstory: the Biden administration's nucleic acid screening framework was ordered dismantled by Trump executive order in May 2025, a 90-day replacement deadline passed months ago with nothing published, and the Senate bill the letter is designed to move has been sitting in committee since early 2026. The ask is a supply-chain fix, not an AI fix — and the gap between what these companies are asking Congress to build and what their own researchers have shown can already defeat existing screening is the tension worth watching.